Colgate Oral Health Network

Cancer therapy can lead to a number of side-effects that can impact oral health and dental care.

This two-part course will present the most common oral complications of cancer therapy and their impacts on dental care. Case Discussions are included to emphasize real-world application of the material in your practice. Part 2 presents the oral complications of radiation therapy for head and neck cancer, as well as medication-related osteonecrosis of the jaw (MRONJ) in patients with cancer. Topics covered include radiation-induced oral mucositis, hyposalivation/xerostomia, oral infections, osteoradionecrosis, implications for dental care before and after radiation therapy, and MRONJ in oncology patients.

Participants will learn:

  • To recognize and manage the oral complications of radiation therapy for head and neck cancer
  • To recognize and manage medication-related osteonecrosis of the jaw (MRONJ) in oncology patients
  • To understand the implications for dental care before, during, and after cancer therapy

Presenters:

Rajesh Lalla

Rajesh Lalla DDS, PhD; Professor of Oral Medicine

More courses with Rajesh Lalla

Dr. Rajesh V. Lalla is a Professor of Oral Medicine and Associate Dean for Research at the UConn School of Dental Medicine. He is a clinician-scientist who conducts clinical research on oral complications of cancer therapy. His research has been funded by the US National Institutes of Health (NIH), foundations, and industry. Dr. Lalla has published over 100 articles in peer-reviewed journals, many of them dealing with oral complications of cancer therapy. He has been invited to speak on this topic at several national and international meetings.

Financial disclosure: Rajesh Lalla has received an honorarium from Colgate-Palmolive Company.

"Oral Complications of Cancer Therapy Part 2: Radiation Therapy and Medication-related Osteonecrosis of the Jaw" has been planned and implemented in accordance with the standards of the AGD Pace and is supported by funds received from Colgate Oral Pharmaceuticals Inc. Tribune Group GmbH is a recognized AGD Pace provider. At the end of the webinar, after passing the C.E. Quiz, you will be able to download your AGD Pace C.E. Certificate.

OTHER WEBINARS YOU MAY BE INTERESTED IN

On-demand webinar

Managing Patients with Polypharmacy
Ann Eshenaur Spolarich

Ann Eshenaur Spolarich RDH, PhD, FSCDH, Professor and Assistant Dean for Research, Arizona School of Dentistry & Oral Health, A.T. Still University

Managing Patients with Polypharmacy

On-demand webinar

Comparative Dentistry: Common Orofacial Conditions in Dogs and Cats
John Lewis

John Lewis VMD, FAVD, DAVDC, FF-AVDC OMFS

Comparative Dentistry: Common Orofacial Conditions in Dogs and Cats